Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis
Condition(s):OsteoporosisLast Updated:May 31, 2022Recruiting
Include Studies Not Open or Pending
Condition(s):OsteoporosisLast Updated:May 31, 2022Recruiting
Condition(s):Sickle Cell Disease; Sickle Cell Anemia; Osteonecrosis; Ischemic Necrosis; Avascular NecrosisLast Updated:February 22, 2024Not yet recruiting
Condition(s):Denosumab AllergyLast Updated:February 21, 2023Recruiting
Condition(s):Bone Quality Assessment; Preserved Sockets; Sodium Alendronate; Sticky BoneLast Updated:March 16, 2023Recruiting
Condition(s):Osteoporosis, PostmenopausalLast Updated:December 5, 2023Recruiting
Condition(s):Knee OsteoarthritisLast Updated:April 22, 2022Recruiting
Condition(s):OsteoporosisLast Updated:October 25, 2021Recruiting
Condition(s):OsteoporosisLast Updated:March 31, 2022Not yet recruiting
Condition(s):ACL ReconstructionLast Updated:February 15, 2024Recruiting
Condition(s):Nonalcoholic Fatty Liver; Osteoporosis, PostmenopausalLast Updated:July 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.